Qualitative interviews to understand health care providers’ experiences of prescribing licensed peanut oral immunotherapy

OBJECTIVE: This research sought to explore health care providers’ (HCPs) experiences of delivering the first US Food and Drug Administration (FDA) and European Commission (EC) approved peanut oral immunotherapy (peanut OIT; Palforzia). Semi-structured qualitative interviews with HCPs who had initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Anagnostou, Aikaterini, Lawrence, Claire, Tilles, Stephen A., Laubach, Susan, Donelson, Sarah M., Yassine, Mohamed, Nowak-Wegrzyn, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358114/
https://www.ncbi.nlm.nih.gov/pubmed/35941597
http://dx.doi.org/10.1186/s13104-022-06161-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358114/
https://www.ncbi.nlm.nih.gov/pubmed/35941597
http://dx.doi.org/10.1186/s13104-022-06161-6

Ejemplares similares